Use of neuromuscular blockers in Brazil
Uso de bloqueadores neuromusculares no Brasil
Giovani de Figueiredo Locks; Ismar Lima Cavalcanti; Nadia Maria Conceição Duarte; Rafael Martins da Cunha; Maria Cristina Simões de Almeida
Abstract
Keywords
Resumo
Palavras-chave
References
Berg H, Roed J, Viby-Mogensen J,. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postopera- tive pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997;41:1095-103.
Mathias LA, da ST, de Bernardis RCG. Postoperative residual paralysis. Rev Bras Anestesiol. 2012;62:439-50.
Warner MA. Perioperative mortality: intraoperative anesthetic management matters. Anesthesiology. 2005;102:251-2.
Brull SJ, Naguib M, Miller RD. Residual neuromuscular block: rediscovering the obvious. Anesth Analg. 2008;107:11-4.
Eikermann M, Vogt FM, Herbstreit F,. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med. 2007;175:9-15.
Eriksson LI, Sato M, Severinghaus JW. Effect of a vecuronium- induced partial neuromuscular block on hypoxic ventilatory response. Anesthesiology. 1993;78:693-9.
Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: Definitions, incidence, and adverse physi- ologic effects of residual neuromuscular block. Anesth Analg. 2010;111:120-8.
Fuchs-Buder T, Claudius C, Skovgaard LT,. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007;51:789-808.
Eikermann M, Groeben H, Hüsing J,. Accelerometry of adductor pollicis muscle recovery of predicts respiratory function from neuromuscular blockade. Anesthesiology. 2003;98:1333-7.
Mortensen CR, Berg H, el-Mahdy A,. Perioperative moni- toring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium. Acta Anaesthesiol Scand. 1995;39:797-801.
Gätke MR, Viby-Mogensen J, Rosenstock C,. Postopera- tive muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand. 2002;46:207-13.
Sorgenfrei IF, Viby-Mogensen J, Swiatek FA. Does evidence lead to a change in clinical practice? Danish anaesthetists' and nurse anesthetists' clinical practice and knowledge of postoperative residual curarization. Ugeskr Laeger. 2005;167:3878-82.
Fuchs-Buder T, Hofmockel R, Geldner G,. The use of neuro- muscular monitoring in Germany. Anaesthesist. 2003;52:522-6.
Grayling M, Sweeney BP. Recovery from neuromuscular block- ade: a survey of practice. Anaesthesia. 2007;62:806-9.
Almeida MCS. O uso de bloqueadores neuromusculares no Brasil. Rev Bras Anestesiol. 2004;54:850-64.
Naguib M, Kopman AF, Lien CA,. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010;111:110-9.
Phillips S, Stewart PA, Bilgin AB. A survey of the management of neuromuscular blockade monitoring in Australia and New Zealand. Anaesth Intensive Care. 2013;41:374-9.
Beny K, Piriou V, Dussart C,. Impact of sugammadex on neuromuscular blocking agents use: a multicentric, pharmaco- epidemiologic study in French university hospitals and military hospitals. Ann Fr Anesth Reanim. 2013;32:838-43.
Sadleir PHM, Clarke RC, Bunning DL,. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth. 2013;110:981-7.
Mertes PM, Tajima K, Regnier- Kimmoun MA. Perioperative anaphylaxis. Med Clin North Am. 2010;94:761-89.
Dewachter P, Mouton-Faivre C, Emala CW. Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology. 2009;111:1141-50.
Dong SW, Mertes PM, Petitpain N,. Hypersensitivity reac- tions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiol. 2012;78:868-78.
Eldawlatly A, El- Tahan MR. A survey of the current use of neuromuscular blocking drugs among the Middle Eastern anes- thesiologists. Saudi J Anaesth. 2013;7:146-50.
Sørensen MK, Bretlau C, Gätke MR,. Rapid sequence induction and intubation with rocuronium-sugammadex com- pared with succinylcholine: a randomized trial. Br J Anaesth. 2012;108:682-9.
Baillard C. Incidence and complications of post operative resid- ual paralysis. Ann Fr Anesth Reanim. 2009;28(^s2):S41-5.
Kotake Y, Ochiai R, Suzuki T,. Reversal with sugammadex in the absence of monitoring did not preclude residual neuro- muscular block. Anesth Analg. 2013;117:345-51.
Di Marco P, Della Rocca G, Iannuccelli F,. Knowledge of residual curarization: an Italian survey. Acta Anaesthesiol Scand. 2010;54:307-12.
Fuchs-Buder T, Meistelman C. Monitoring of neuromuscular block and prevention of residual paralysis. Ann Fr Anesth Reanim. 2009;28(^s2):S46-50.
Esteves S, Martins M, Barros F,. Incidence of postopera- tive residual neuromuscular blockade in the postanaesthesia care unit: an observational multicentre study in Portugal. Eur J Anaesthesiol. 2013;30:243-9.
Kaan N, Kocaturk O, Kurt I,. The incidence of resid- ual neuromuscular blockade associated with single dose of intermediate-acting neuromuscular blocking drugs. Middle East J Anesthesiol. 2012;21:535-41.
Kumar GV, Nair AP, Murthy HS,. Residual neuromuscular blockade affects postoperative pulmonary function. Anesthesi- ology. 2012;117:1234-44.
Cedborg AIH, Sundman E, Bodén K,. Pharyngeal func- tion and breathing pattern during partial neuromuscular block in the elderly: effects on airway protection. Anesthesiology. 2014;120:312-25.
Mertes PM, Alla F, Tréchot P,. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol. 2011;128:366-73.
Chong YY, Caballero MR, Lukawska J,. Anaphylaxis dur- ing general anaesthesia: one-year survey from a British allergy clinic. Singap Med J. 2008;49:483-7.
Karanovi´c N, Carev M, Kardum G,. Succinylcholine use in adult anesthesia - a multinational questionnaire survey. Coll Antropol. 2011;35(^s1):183-90.
Abrishami A, Ho J, Wong J,. Sugammadex, a selec- tive reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane database Syst Rev. 2009:CD007362.
Hopkins PM. Malignant hyperthermia: pharmacology of trigger- ing. Br J Anaesth. 2011;107:48-56.
Murphy GS, Szokol JW, Avram MJ,. Postoperative resid- ual neuromuscular blockade is associated with impaired clinical recovery. Anesth Analg. 2013;117:133-41.
Murphy GS, Szokol JW, Marymont JH,. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130-7.